Sherman S I
Section of Endocrine Neoplasia and Hormonal Disorders, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Semin Surg Oncol. 1999 Jan-Feb;16(1):30-3. doi: 10.1002/(sici)1098-2388(199901/02)16:1<30::aid-ssu6>3.0.co;2-h.
As with most therapies for differentiated thyroid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followed by thyroid hormone suppression therapy. An approach to long-term monitoring and therapy is provided, including the use of strategies dependent upon the extent of the patient's initial disease.
与大多数分化型甲状腺癌的治疗方法一样，对于术后辅助治疗的最佳使用或长期随访策略，几乎没有共识。然而，越来越多的数据表明，大多数患者可从术后放射性碘消融及随后的甲状腺激素抑制治疗中获益。本文提供了一种长期监测和治疗方法，包括根据患者初始疾病的程度采用相应策略。
